Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
2
Neutral
7
Bullish
5
Bearish
13
Neutral
7
Bullish
26
Bearish
11
Neutral
0
Bullish
21
Discovery themes featuring this stock| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
9.10 | 221 Cr | 11.64 | 0.99 | 0.00 | 8.29 | 9.09 | 6.02 | ||
74.92 | 212 Cr | 53.51 | 1.41 | 0.00 | 2.64 | 5.20 | 1.52 | ||
582.00 | 208 Cr | 12.86 | 0.99 | 0.34 | 7.83 | 10.89 | 6.81 | ||
42.02 | 207 Cr | 18.94 | 1.69 | 0.00 | 8.93 | 13.60 | 3.25 | ||
154.05 | 201 Cr | — | 17.63 | 0.00 | -148.86 | -9.23 | -11.80 | ||
10.27 | 200 Cr | — | 0.34 | 0.00 | -9.85 | -8.75 | -47.12 | ||
273.75 | 198 Cr | — | 6.46 | 0.00 | 14.29 | 16.99 | 12.01 | ||
| Median: 7 Co. | — | 74.92 | 207 Cr | 15.90 | 1.41 | 0.00 | 7.83 | 9.09 | 3.25 |
Coral Laboratories Limited (CLL) is a pharmaceutical company focused on manufacturing generic branded, nutraceuticals, OTC, and herbal medicines across India.
The company operates three production facilities located in Daman and Dehradun, enhancing its manufacturing capacity and scope.
Originally promoted by Navin B Doshi of the DWD group, Coral Labs raised Rs. 2.5 crores through a public issue to expand its manufacturing capabilities.
Coral Laboratories began commercial production at its ultra-modern unit in Daman in March 2004 and its plant in Dehradun in September 2006.
Pharmaceuticals & Biotechnology
Pharmaceuticals
208 Cr
Low Risk
12.9
36.7
-0.4
1.0
659.00
360.00
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Coral Laboratories Ltd (CORALAB) is currently trading at 582.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Coral Laboratories Limited (CLL) is a pharmaceutical company focused on manufacturing generic branded, nutraceuticals, OTC, and herbal medicines across India. The company operates three production facilities located in Daman and Dehradun, enhancing its manufacturing capacity and scope. Originally promoted by Navin B Doshi of the DWD group, Coral Labs raised Rs. 2.5 crores through a public issue to expand its manufacturing capabilities. Coral Laboratories began commercial production at its ultra-modern unit in Daman in March 2004 and its plant in Dehradun in September 2006.
Over the past 52 weeks, Coral Laboratories Ltd has traded between a low of ₹360.00 and a high of ₹659.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Coral Laboratories Ltd has a market capitalization of approximately 207.76. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Coral Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.86 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 207.76 Cr, Coral Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Coral Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Coral Laboratories Ltd is 12.86. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Regulatory/Compliance Filing
Coral Laboratories reports postal ballot e-voting results: ordinary resolution to increase remuneration and other facilities to Ms. Meera Doshi passed; scrutinizer's report enclosed. Voting concluded July 22, 2026.
Regulatory/Compliance Filing
Coral Laboratories declared postal ballot e-voting results: ordinary resolution to increase remuneration and other facilities to Ms. Meera Doshi passed. Scrutinizer's report enclosed. Voting concluded July 22, 2026.
Regulatory/Compliance Filing
Coral Laboratories Ltd announced postal ballot results: ordinary resolution passed approving increase in remuneration and other facilities to Ms. Meera Doshi; postal ballot concluded on 2026-07-22; scrutinizer report attached.
Regulatory/Compliance Filing
Coral Laboratories announces postal ballot result: Ordinary resolution passed to increase remuneration and other facilities to Ms. Meera Doshi; voting concluded on July 22, 2026 and scrutinizer report enclosed.
